Regular exercise has a number of benefits, including increasing cardiovascular health, burning more calories, and building muscle, says Ali
Why Fat Loss From GLP-1 Medications Help the Heart Clinical trials consistently show that Semaglutide leads to 10-15% total body weight loss in many individuals, even without diabetes
In December 2024 tirzepatide was approved by the FDA for the treatment of moderate to severe obstructive sleep apnea in adults with obesity
While large randomized trials do not specifically measure UTI incidence, mechanistic studies show GLP-1 agonists reduce fluid intake, concentrate urine, and alter glucose handlingall factors that increase UTI risk
Four, 1 and 6 studies were categorized as having high risk, medium risk and unclear risk of detection bias, respectively
However, when combined with another drug called phentermine as the brand-name drug Qsymia, it is FDA-approved as a weight loss medication for: Adults and pediatric patients aged 12 years and older with obesity (a BMI of 30 or greater) Adults who are overweight (a BMI of 27 or greater) and at least one weight-related condition, like type 2 diabetes or high blood pressure It is important to know that Qsymia is classified as a Schedule IV controlled substance